SentiSense Logo

SentiSense

Ctrl+K

55% OFF

Quick tip: Press

K

to search stocks

W

WST

West Pharmaceutical Services, Inc.

$245.86

+1.51 (+0.62%)

Summary

Stories

News

Metrics

Fundamentals

Current Market Valuation

Current Price

$245.86

Live market price

P/E (TTM)

36.21

EPS: $6.79

P/S (TTM)

5.76

Price to Sales

TTM Quarters

4

Quarters included in TTM

Updated: 3/8/2026, 5:56:50 AM

Historical Trends

Range:

Revenue Over Time

Q1 2021Q2 2022Q3 2023Q4 2025$0B$0B$1B$1B$1B

Net Income Over Time

Q1 2021Q2 2022Q3 2023Q4 2025$0B$0B$0B$0B$0B

Short Interest (% of Float) Over Time

02/2805/3008/2902/130.0%5.0%10.0%15.0%20.0%High SI

Short Interest

2.2M

% of Float

3.1%

Days to Cover

1.7

Avg Daily Vol

1.4M

Historical income statement data up to 5 years


Historical SEC Filings

Report Period

Debt/Equity

0.06

Leverage ratio

ROE (TTM)

15.54%

Return on equity

Income Statement

Revenue

$3.07B


Cost of Revenue

$1.97B


Gross Profit

$1.10B


Operating Income

$584.90M


Net Income

$493.70M


EPS (Quarter)

$6.79


EPS (TTM)

--

Balance Sheet

Total Assets

$4.27B


Total Liabilities

$1.09B


Shareholders' Equity

$3.18B


Current Assets

$1.98B


Current Liabilities

$654.90M


Cash & Equivalents

--


Long-Term Debt

$202.80M

Cash Flow

Operating Cash Flow

$754.80M


Investing Cash Flow

$-285.90M


Financing Cash Flow

$-185.10M


Free Cash Flow

$468.90M

Profitability Margins

Gross Margin

35.91%

Operating Margin

19.03%

Net Profit Margin

16.06%


ROA (TTM)

11.56%


ROE (TTM)

15.54%

Data source: Polygon.io

Last updated: 3/8/2026, 5:56:51 AM

Company Profile

Symbol

WST


Market Cap

$17.71B


IPO Date

Jan 2, 1973


CEO

--


Employees

10,800


Sector

--


Industry

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS


Country

United States


Exchange

--

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Read More
SentiSense Logo

SentiSense

Sense what the market is doing.

© 2026 Compass AI Data Services, LLC. All rights reserved.


Important Disclaimer: Compass AI Data Services, LLC provides market information, sentiment analysis, and data intelligence. We do not provide investment advice, recommendations, or financial guidance. All information is for informational purposes only. Users are solely responsible for their own investment decisions. Always consult a licensed financial advisor before making investment decisions.

Cookie Preferences

We use cookies to enhance your experience and analyze site traffic. Privacy Policy